🚨NEW PAPER🚨 Huge congrats to @KamKaplanRFUMS on his first first-author data paper and @Lainey10yes on her first ever publication!! Seriously so proud of this lab always. Summary below (2-4). https://t.co/sFU51opkDp
If you’re still around, I would love to chat about NPSs in Alzheimer’s disease and novel therapeutics for age-related mood disorders tonight! @ACNPorg#ACNP2026
Closed out 2025 with 3 new publications! Proud to be a part of these collaborative teams.
https://t.co/1zO2O0bmNA (BZDs and dementia review)
https://t.co/1hcu9Ie9KH (Lifestyle impact on the brain review)
https://t.co/srBidRLjS8 (LatinX Women in Research & Innovation)
How do sex, stress & anxiety shape risk for Alzheimer’s disease?
Join Dr. Holly Hunsberger on Sept 15 for our next #WHSS talk on vulnerabilities to aging & AD.
📅 Sept 15 | 12pm ET
💻 Free, virtual — register today: https://t.co/YzNRIgReLY
#Alzheimers#Research#WomensHealth
. @ACNPorg panel not selected 😭😭 but I would still love to attend!
Anyone have a guest slot available for a past travel awardee who is applying for membership this year? 🙏
📣 Today is a turning point in what we know about brain health.
The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S.
The findings, shared for the first time today at #AAIC25, tested lifestyle programs that simultaneously targeted risk factors. The programs focused on:
✅👟Aerobic exercise
✅🧠Cognitive engagement
✅🥗Nutrition
✅🫀Health Monitoring
U.S. POINTER is the largest research commitment the Association has made in its history. The landmark results are testament to our commitment to our mission. Thank you to the study participants, our community, our donors, and the staff who made these findings possible.
https://t.co/RDqYXQl0Kq
And they’re off! 🏃🏿♀️➡️🏃🏽♂️➡️🏃🏻♀️➡️ This morning, #AAIC25 attendees are enjoying stunning waterfront views as they make their way down Toronto’s scenic Martin Goodman Trail during our AAIC 5K Run/Walk.
Excited to see this work out! Combination therapy could be the future of AD treatments. Loved being a part of this study during my time in the Denny lab bridging the ketamine and AD crews. @BriKChen@DrChristineAnnD#ENDALZ
https://t.co/Lhj4nq3KNP
@JasonSynaptic Also hurts ESI! I easily submit 6 NIH grants a year just on resubmissions alone. I've put in R03-R21- R01- and DP2 to give myself a shot. It's rough out here 😅
We need to talk about the effects of US science funding cuts on the lives of scientists and on the future of discovery & innovation in this country. I am proud to be joining a panel led by @BioRender ft. speakers from across disciplines, career stages, and roles in science (1/3)
My favorite is the Summer lab explosion. I’m always impressed with the passion and new ideas from our summer interns and volunteers!! Thanks Tala Coffee Roasters for an awesome lab meeting space ☕️. Not pictured: My orange juice coffee combo 🤯.
🚨NEW PAPER🚨 Huge congrats to @KamKaplanRFUMS on his first first-author data paper and @Lainey10yes on her first ever publication!! Seriously so proud of this lab always. Summary below (2-4). https://t.co/sFU51opkDp
Here, we examine the acute effects of Xanax on fear memory and activated neuronal ensembles. With a single injection, we found memory impairment in both males and females and alterations in hippocampal encoding and retrieval cell activation, specifically in females.